Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Martin

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura S Wood, Paul Elson, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.
The European Respiratory Journal|December 18, 2020
The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trialChristine R Jenkins, Fu-Qiang Wen, Allison Martin, et al.
Journal for Immunotherapy of Cancer|October 19, 2018
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumabHaris Zahoor, Pedro C Barata, Xuefei Jia, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2022
Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS TrialThomas Bradbury, Gian Luca Di Tanna, Anish Scaria, et al.
Lung|April 7, 2021
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist GefapixantAlyn H Morice, Surinder S Birring, Jaclyn A Smith, et al.
Clinical Genitourinary Cancer|March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint InhibitorsMoshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2021
Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical PracticeIssam S Hamadeh, Donald C Moore, Allison Martin, et al.
Molecular Metabolism|September 27, 2025
Weight loss reverses obesity-associated impairments in acute gastrointestinal stretch-induced suppression of food intake and glucose homeostasisMaigen Bethea, Tyler Cook, Marwa Mommandi, et al.
Clinical Genitourinary Cancer|November 6, 2023
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell CarcinomaJames Schuster, Iris Y Sheng, Chandana A Reddy, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura S Wood, Paul Elson, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.
The European Respiratory Journal|December 18, 2020
The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trialChristine R Jenkins, Fu-Qiang Wen, Allison Martin, et al.
Journal for Immunotherapy of Cancer|October 19, 2018
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumabHaris Zahoor, Pedro C Barata, Xuefei Jia, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2022
Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS TrialThomas Bradbury, Gian Luca Di Tanna, Anish Scaria, et al.
Lung|April 7, 2021
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist GefapixantAlyn H Morice, Surinder S Birring, Jaclyn A Smith, et al.
Clinical Genitourinary Cancer|March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint InhibitorsMoshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2021
Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical PracticeIssam S Hamadeh, Donald C Moore, Allison Martin, et al.
Molecular Metabolism|September 27, 2025
Weight loss reverses obesity-associated impairments in acute gastrointestinal stretch-induced suppression of food intake and glucose homeostasisMaigen Bethea, Tyler Cook, Marwa Mommandi, et al.
Clinical Genitourinary Cancer|November 6, 2023
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell CarcinomaJames Schuster, Iris Y Sheng, Chandana A Reddy, et al.
Pageof 12